| 1.2 |
6.0 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.7 |
2.2 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.7 |
2.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 |
2.8 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.3 |
1.8 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
0.9 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 |
1.4 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
0.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
1.3 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.2 |
0.4 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.2 |
1.2 |
GO:0051096 |
telomere assembly(GO:0032202) positive regulation of helicase activity(GO:0051096) |
| 0.2 |
0.8 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 |
1.6 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.8 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
2.2 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.5 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
0.3 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
1.1 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
1.1 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 |
0.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 |
0.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.5 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.2 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.6 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.1 |
0.8 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.0 |
0.2 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 |
0.4 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.0 |
0.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
1.6 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
1.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.2 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.0 |
0.2 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.2 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.9 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 |
0.8 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.4 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.0 |
0.3 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.0 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.0 |
0.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.3 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.8 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
1.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
0.4 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 |
0.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
0.5 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.1 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.6 |
GO:0050817 |
blood coagulation(GO:0007596) coagulation(GO:0050817) |
| 0.0 |
0.1 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
2.3 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.7 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.6 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.8 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
